Activor was developed to bring to market products that are based on novel peptide chemistry. Activor’s principle focus to date has been in the development of products for the skin care, dermaceutical
and wound care industries.
Activor products are tested for toxicity and efficacy in a manner consistent with the rules and regulations of the
Food and Drug Administration. Consequently, product development includes in vitro
and in vivo testing, third party confirmation of basic science findings, and evaluation by qualified physicians at prominent
universities around the globe.
Activor’s focus since its inception has been on the forefront of the burgeoning fields of bio-engineered peptides
and dermaceutical science. To that end, it has created new procedures and techniques
that have yielded substantial advances in dermaceutical science and wound care.
